Corvus Pharmaceuticals (CRVS) Return on Equity [ROE] (2016 - 2026)
Corvus Pharmaceuticals (CRVS) posted Return on Equity [ROE] of -20.51% for Q2 2026, up 33.67 percentage points from -54.18% a year earlier but down 10.70 percentage points from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2023, Corvus Pharmaceuticals' Return on Equity [ROE] came in at -46.04%, down 4.40 percentage points from FY2022.
- Annual Return on Equity [ROE] shows a five-year change of +2.06 percentage points (FY2018 to FY2023).
- In prior years, Corvus Pharmaceuticals' Return on Equity [ROE] was -41.64% in FY2022 (+4.01 pp), -45.65% in FY2021 (+14.69 pp), -60.34% in FY2020 (-8.89 pp) and -51.44% in FY2019 (-3.34 pp).
- Quarterly Return on Equity [ROE] has run from a low of -171.06% in Q3 2024 to a high of -9.81% in Q1 2026 over five years.
- On a year-over-year basis, Return on Equity [ROE] increased in three of the last six quarters, with an average year-over-year change of +11.53 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2025, with a gain of 116.79 percentage points; the weakest was Q3 2024, with a drop of 124.47 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - | -20.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.51% |
| Mar 31, 2026 | -9.81% |
| Sep 30, 2025 | -54.27% |
| Jun 30, 2025 | -54.18% |
| Mar 31, 2025 | -81.63% |
| Sep 30, 2024 | -171.06% |
| Jun 30, 2024 | -47.35% |
| Mar 31, 2024 | -59.85% |
| Dec 31, 2023 | -52.47% |
| Sep 30, 2023 | -46.59% |
| Jun 30, 2023 | -58.89% |
| Mar 31, 2023 | -58.39% |
| Dec 31, 2022 | -52.83% |
| Sep 30, 2022 | -46.02% |
| Jun 30, 2022 | -35.50% |
| Mar 31, 2022 | -36.99% |
| Dec 31, 2021 | -38.20% |
| Sep 30, 2021 | -41.38% |
| Jun 30, 2021 | -44.49% |
| Mar 31, 2021 | -50.16% |
API Access
Corvus Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();